AIM
OPNT

Alambic Investment Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Alambic Investment Management’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,312
Closed -$138K – 172
2020
Q2 		$138K Hold
15,312
– – 0.35% 114
2020
Q1 		$147K Buy
+15,312
New +$183K 0.36% 106

Other funds holding OPNT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alambic Investment Management's OPNT Position: Q3 2020 in Review

Alambic Investment Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q3 2020, closing a stake of 15,312 shares — an estimated $138K sold.

Alambic Investment Management first reported a position in OPNT in Q1 2020 and held it in 2 quarters. The position peaked at $147K in Q1 2020. 28 funds tracked by Wall St. Rank hold OPNT as of Q3 2020.

  • Alambic Investment Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Alambic Investment Management sold 15,312 Opiant Pharmaceuticals, Inc. Common Stock shares in Q3 2020, an estimated $138K.
  • Alambic Investment Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 2 quarters.
  • Alambic Investment Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $147K in Q1 2020.
  • 28 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q3 2020.

Based on Alambic Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.